Metrics to compare | RAFA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipRAFAPeersSector | |
|---|---|---|---|---|
P/E Ratio | 15.2x | −0.5x | −0.3x | |
PEG Ratio | - | 0.00 | 0.00 | |
Price/Book | - | 0.8x | 2.6x | |
Price / LTM Sales | 3.6x | 0.6x | 2.9x | |
Upside (Analyst Target) | - | 0.0% | 57.8% | |
Fair Value Upside | Unlock | 6.0% | 9.5% | Unlock |
Rafa Laboratories Ltd., a pharmaceutical company, manufactures, markets, and distributes prescription (Rx) and over-the-counter (OTC) medicines in Israel. The company offers sterile and aseptic injectable products, as well as formulations for combination devices such as auto-injectors. It also offers primary and secondary packaging solutions, including blisters, bottles, tubes, ampoules, cartridges, suppositories, and serialization services. In addition, it develops and offers auto-injector products for emergency use and protection against chemical warfare, as well as products to treat trauma, pain, and additional ABC (atomic, biological, and chemical) threats. The company was founded in 1937 and is based in Jerusalem, Israel.